Human Serum Albumin Nanoparticles: Synthesis, Optimization and Immobilization with Antituberculosis Drugs

The aim of this study was to create nanoparticles of human serum albumin immobilized with anti-TB drugs (rifampicin, isoniazid) using the desolvation method. Central Composite Design (CCD) was applied to study the effect of albumin, urea, L-cysteine, rifampicin and isoniazid concentration on particl...

Full description

Bibliographic Details
Main Authors: Aldana Galiyeva, Arailym Daribay, Tolkyn Zhumagaliyeva, Lyazzat Zhaparova, Daniyar Sadyrbekov, Yerkeblan Tazhbayev
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Polymers
Subjects:
Online Access:https://www.mdpi.com/2073-4360/15/13/2774
_version_ 1797590992641064960
author Aldana Galiyeva
Arailym Daribay
Tolkyn Zhumagaliyeva
Lyazzat Zhaparova
Daniyar Sadyrbekov
Yerkeblan Tazhbayev
author_facet Aldana Galiyeva
Arailym Daribay
Tolkyn Zhumagaliyeva
Lyazzat Zhaparova
Daniyar Sadyrbekov
Yerkeblan Tazhbayev
author_sort Aldana Galiyeva
collection DOAJ
description The aim of this study was to create nanoparticles of human serum albumin immobilized with anti-TB drugs (rifampicin, isoniazid) using the desolvation method. Central Composite Design (CCD) was applied to study the effect of albumin, urea, L-cysteine, rifampicin and isoniazid concentration on particle size, polydispersity and loading degree of the drugs. The optimized nanoparticles were spherical in shape with an average particle size of 216.7 ± 3.7 nm and polydispersity of 0.286 ± 4.9. The loading degree of rifampicin and isoniazid in the optimized nanoparticles were 44% and 27%, respectively. The obtained nanoparticles were examined by Fourier-transform infrared spectroscopy (FTIR), thermogravimetric analysis (TGA) and differential scanning calorimetry (DSC); the results showed the absence of drug–polymer interactions. The drug release from the polymer matrix was studied using dialysis membranes.
first_indexed 2024-03-11T01:31:21Z
format Article
id doaj.art-6ed559562efa4ef7a522ba43df0e8d4e
institution Directory Open Access Journal
issn 2073-4360
language English
last_indexed 2024-03-11T01:31:21Z
publishDate 2023-06-01
publisher MDPI AG
record_format Article
series Polymers
spelling doaj.art-6ed559562efa4ef7a522ba43df0e8d4e2023-11-18T17:19:53ZengMDPI AGPolymers2073-43602023-06-011513277410.3390/polym15132774Human Serum Albumin Nanoparticles: Synthesis, Optimization and Immobilization with Antituberculosis DrugsAldana Galiyeva0Arailym Daribay1Tolkyn Zhumagaliyeva2Lyazzat Zhaparova3Daniyar Sadyrbekov4Yerkeblan Tazhbayev5Institute of Chemical Problems, Karagandy University of the Name of Academician E.A. Buketov, Karaganda City 100028, KazakhstanInstitute of Chemical Problems, Karagandy University of the Name of Academician E.A. Buketov, Karaganda City 100028, KazakhstanInstitute of Chemical Problems, Karagandy University of the Name of Academician E.A. Buketov, Karaganda City 100028, KazakhstanInstitute of Chemical Problems, Karagandy University of the Name of Academician E.A. Buketov, Karaganda City 100028, KazakhstanInstitute of Chemical Problems, Karagandy University of the Name of Academician E.A. Buketov, Karaganda City 100028, KazakhstanInstitute of Chemical Problems, Karagandy University of the Name of Academician E.A. Buketov, Karaganda City 100028, KazakhstanThe aim of this study was to create nanoparticles of human serum albumin immobilized with anti-TB drugs (rifampicin, isoniazid) using the desolvation method. Central Composite Design (CCD) was applied to study the effect of albumin, urea, L-cysteine, rifampicin and isoniazid concentration on particle size, polydispersity and loading degree of the drugs. The optimized nanoparticles were spherical in shape with an average particle size of 216.7 ± 3.7 nm and polydispersity of 0.286 ± 4.9. The loading degree of rifampicin and isoniazid in the optimized nanoparticles were 44% and 27%, respectively. The obtained nanoparticles were examined by Fourier-transform infrared spectroscopy (FTIR), thermogravimetric analysis (TGA) and differential scanning calorimetry (DSC); the results showed the absence of drug–polymer interactions. The drug release from the polymer matrix was studied using dialysis membranes.https://www.mdpi.com/2073-4360/15/13/2774nanoparticlesalbuminrifampicinisoniazidantituberculosis drugsdesolvation
spellingShingle Aldana Galiyeva
Arailym Daribay
Tolkyn Zhumagaliyeva
Lyazzat Zhaparova
Daniyar Sadyrbekov
Yerkeblan Tazhbayev
Human Serum Albumin Nanoparticles: Synthesis, Optimization and Immobilization with Antituberculosis Drugs
Polymers
nanoparticles
albumin
rifampicin
isoniazid
antituberculosis drugs
desolvation
title Human Serum Albumin Nanoparticles: Synthesis, Optimization and Immobilization with Antituberculosis Drugs
title_full Human Serum Albumin Nanoparticles: Synthesis, Optimization and Immobilization with Antituberculosis Drugs
title_fullStr Human Serum Albumin Nanoparticles: Synthesis, Optimization and Immobilization with Antituberculosis Drugs
title_full_unstemmed Human Serum Albumin Nanoparticles: Synthesis, Optimization and Immobilization with Antituberculosis Drugs
title_short Human Serum Albumin Nanoparticles: Synthesis, Optimization and Immobilization with Antituberculosis Drugs
title_sort human serum albumin nanoparticles synthesis optimization and immobilization with antituberculosis drugs
topic nanoparticles
albumin
rifampicin
isoniazid
antituberculosis drugs
desolvation
url https://www.mdpi.com/2073-4360/15/13/2774
work_keys_str_mv AT aldanagaliyeva humanserumalbuminnanoparticlessynthesisoptimizationandimmobilizationwithantituberculosisdrugs
AT arailymdaribay humanserumalbuminnanoparticlessynthesisoptimizationandimmobilizationwithantituberculosisdrugs
AT tolkynzhumagaliyeva humanserumalbuminnanoparticlessynthesisoptimizationandimmobilizationwithantituberculosisdrugs
AT lyazzatzhaparova humanserumalbuminnanoparticlessynthesisoptimizationandimmobilizationwithantituberculosisdrugs
AT daniyarsadyrbekov humanserumalbuminnanoparticlessynthesisoptimizationandimmobilizationwithantituberculosisdrugs
AT yerkeblantazhbayev humanserumalbuminnanoparticlessynthesisoptimizationandimmobilizationwithantituberculosisdrugs